Histogen (HSTO) Competitors $0.03 +0.00 (+7.01%) As of 04/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HSTO vs. MYMD, KRBP, CAPS, VRPX, TFFP, TCBP, BON, UPC, ADTX, and NAVBShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include MyMD Pharmaceuticals (MYMD), Kiromic BioPharma (KRBP), Capstone (CAPS), Virpax Pharmaceuticals (VRPX), TFF Pharmaceuticals (TFFP), TC Biopharm (TCBP), Bon Natural Life (BON), Universe Pharmaceuticals (UPC), Aditxt (ADTX), and Navidea Biopharmaceuticals (NAVB). These companies are all part of the "pharmaceutical products" industry. Histogen vs. MyMD Pharmaceuticals Kiromic BioPharma Capstone Virpax Pharmaceuticals TFF Pharmaceuticals TC Biopharm Bon Natural Life Universe Pharmaceuticals Aditxt Navidea Biopharmaceuticals Histogen (NASDAQ:HSTO) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability. Is HSTO or MYMD more profitable? Histogen's return on equity of 0.00% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets HistogenN/A N/A N/A MyMD Pharmaceuticals N/A -179.05%-108.14% Which has stronger earnings and valuation, HSTO or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than Histogen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogen$19K7.20-$10.62M-$2.81-0.01MyMD PharmaceuticalsN/AN/A-$4MN/AN/A Does the MarketBeat Community favor HSTO or MYMD? Histogen received 7 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformHistogenOutperform Votes758.33% Underperform Votes541.67% MyMD PharmaceuticalsN/AN/A Which has more risk and volatility, HSTO or MYMD? Histogen has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. Do insiders and institutionals believe in HSTO or MYMD? 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 3.3% of Histogen shares are owned by company insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor HSTO or MYMD? In the previous week, MyMD Pharmaceuticals had 1 more articles in the media than Histogen. MarketBeat recorded 1 mentions for MyMD Pharmaceuticals and 0 mentions for Histogen. MyMD Pharmaceuticals' average media sentiment score of 1.14 beat Histogen's score of 0.00 indicating that MyMD Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Histogen Neutral MyMD Pharmaceuticals Positive SummaryHistogen and MyMD Pharmaceuticals tied by winning 5 of the 10 factors compared between the two stocks. Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$137,000.00$6.74B$5.50B$7.96BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-0.017.3822.6318.55Price / Sales7.20241.88397.30103.38Price / CashN/A65.8538.1834.62Price / Book0.016.476.704.25Net Income-$10.62M$143.68M$3.23B$248.27M7 Day PerformanceN/A1.85%1.36%1.28%1 Month PerformanceN/A6.73%3.85%3.75%1 Year PerformanceN/A-2.72%15.87%5.31% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.03+7.0%N/A-91.5%$137,000.00$19,000.00-0.0120Gap UpMYMDMyMD PharmaceuticalsN/A$0.17-6.4%N/A-92.8%$406,000.00N/A0.006Gap DownHigh Trading VolumeKRBPKiromic BioPharmaN/AN/AN/AN/A$330,000.00N/A-0.0660Upcoming EarningsGap DownHigh Trading VolumeCAPSCapstoneN/A$1.97-3.0%N/AN/A$311,000.00$44.05M0.0038VRPXVirpax Pharmaceuticals0.9624 of 5 stars$0.25-16.7%$75.00+29,900.0%-99.6%$310,000.00N/A0.007TFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289,000.00$-70,983.00-0.0119TCBPTC Biopharm1.3012 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.7%$279,000.00$4.76M0.0080High Trading VolumeBONBon Natural LifeN/A$0.06+0.3%N/A-98.5%$236,000.00$23.84M0.00100Gap UpUPCUniverse PharmaceuticalsN/A$3.81-8.1%N/A-99.7%$163,000.00$26.73M0.00220Gap DownADTXAditxt0.5981 of 5 stars$2.33+4.3%N/A-100.0%$133,000.00$133,985.000.0060NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-98.3%$60,000.00$8,126.000.0010 Related Companies and Tools Related Companies MyMD Pharmaceuticals Competitors Kiromic BioPharma Competitors Capstone Competitors Virpax Pharmaceuticals Competitors TFF Pharmaceuticals Competitors TC Biopharm Competitors Bon Natural Life Competitors Universe Pharmaceuticals Competitors Aditxt Competitors Navidea Biopharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSTO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
